Chlorpheniramine mal.2mg, ephedrine Hcl 5mg, menthol 0.25mg, sodium citrate 40mg/5ml
Therapeutic agent (verify pharmacological class)
What it is used for
Symptomatic relief of cough and hay fever as well as reduction of bronchial and nasal congestion Clinical selection for Chlorpheniramine mal.2mg, ephedrine Hcl 5mg, menthol 0.25mg, sodium citrate 40mg/5ml should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
[From component Chlorpheniramine] Warnings Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland
Possible side effects
[From component Chlorpheniramine] Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.